Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

Ursodeoxycholic Acid Sustained Release Tablets, 450 mg

₹ 6,190/Box

Strength450 mg
Packaging TypeBox
Shelf life24 Months
Pack Size10 x 1 x 10 Tablets
Item NameBriolix-450
Marketed ByBright Biotech
UsageTo treat chronic cholestatic liver diseases
AvailabilityIn Stock
Ursodeoxycholic Acid (UDCA) Sustained Release Tablets are a hepatobiliary therapeutic agent used in the treatment of liver and gallbladder disorders. UDCA is a naturally occurring hydrophilic bile acid that helps reduce cholesterol absorption, dissolve cholesterol gallstones, and protect liver cells from bile acid-induced damage.

Find products similar to Ursodeoxycholic Acid Sustained Release Tablets, 450 Mg

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromGurugram
ShippingAs per delivery location

Product Image

Ursodeoxycholic Acid Sustained Release Tablets, 450 mg-1Ursodeoxycholic Acid Sustained Release Tablets, 450 mg-2Ursodeoxycholic Acid Sustained Release Tablets, 450 mg-3

About the Company

GST Registration Date
Oct 2021
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
40 L - 1.5 Cr
IndiaMART Member Since
Mar 2021
GST
06**********1ZO

At Bright Biotech, we are committed to delivering innovative and affordable healthcare solutions that enhance lives. Established with a vision to bridge the gap between quality and accessibility in pharmaceuticals and nutraceuticals, Bright Biotech stands as a trusted name in the healthcare industry.

Our product portfolio spans a wide range of therapeutic areas including gastroenterology, cardiology, orthopedics, dermatology, nutrition, and critical care, offering formulations such as tablets, capsules, injectables, suspensions, and health supplements.